View of Toxicity, Efficacy, and Quality of Life of Addition of IMRT Boost to Whole Brain Radiation Therapy and Concurrent Temozolomide in Patients with Newly Diagnosed Brain Metastases

Return to Article Details Toxicity, Efficacy, and Quality of Life of Addition of IMRT Boost to Whole Brain Radiation Therapy and Concurrent Temozolomide in Patients with Newly Diagnosed Brain Metastases Download Download PDF